Concepedia

Katia Dotti

KD

Statistics

Publications

18

Citations

713

H-Index

14

Active since

2006

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Milan

Azienda Ospedaliera Treviglio

The University of Texas MD Anderson Cancer Center

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Katia Dotti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and colorectal cancer.

Publications per year

2006–2023

18

Publications

18

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

Bert H. O’Neil, John M. Wallmark, David Lorente et al. · PLoS ONE · 2017 · 305 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF<i>V600E</i>-Mutant<i>KRAS</i>Wild-Type Metastatic Colorectal Cancer

Josep Tabernero, Eric Van Cutsem, Elena Garralda et al. · The Oncologist · 2023 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification

Eric Angevin, Gianluca Spitaleri, Jordi Rodón et al. · European Journal of Cancer · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +15

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer

Emilio Bajetta, Luigi Celio, E. Ferrario et al. · Annals of Oncology · 2007 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Claudio Vernieri, Fabio Galli, Laura Ferrari et al. · The Oncologist · 2019 · 36 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–5 of 18